Speaker illustration

Doctor Victoria Svedung Wettervik

Uppsala University, Uppsala (Sweden)

Member of:

European Society of Cardiology

Resident in Cardiology. PhD.

Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited.

Event: EHRA 2024

Topic: Rhythm Control, Catheter Ablation

Session: Poster session on atrial fibrillation and supraventricular tachycardia

Thumbnail

Clinical outcome of the 2nd generation cryoballoon for pulmonary vein isolation in patients with persistent atrial fibrillation - A sub-study of the randomized trial evaluating single versus dual cryo

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation - Treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb